##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 75 Download : 77

##plugins.themes.academic_pro.article.main##

Abstract

Inflammatory and degenerative spinal diseases are one of the pressing problems of modern rheumatology due to the high prevalence, frequent incidence of diseases of young and middle-aged men, frequent lesions of internal organs, early disability of patients, socio-economic damage caused to the patient and society [1]. Since 1892, when V.M.Bekhterev described the main clinical manifestations of the disease and suggested that it should be singled out as a separate nosological form, researchers from the leading countries of the world have achieved certain success in studying its nature, mechanisms of development, as well as treatment and rehabilitation of patients. Nevertheless, ankylosing spondylitis (AC), which is regarded as a disease of the musculoskeletal apparatus, affecting mainly young men, remains one of the leading socioeconomic problems of our time, leading to disability in working age.

Keywords

relative wall thincness diastolic interventricular septum eccentric hypertrophy

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Ernazarov Dilmurod Oynazar o’gli. (2023). Clinical characteristics of the cardiovascular system involvement in various variants of ankylosing spondylitis. Texas Journal of Medical Science, 23, 19–26. https://doi.org/10.62480/tjms.2023.vol23.pp19-26
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Han C., Robinson D.W.Jr., Hackett M.V. et al. (2006) Cardiovascular disease and risk factors in patients with rheumatoid ar-thritis, psoriatic arthritis, and ankylosing spondylitis. J. Rheumatol., 33(11): 2167–2172.
  2. Heslinga S.C., Peters M., Ter Wee M. Et al. (2015) Re-duction of inflammation drives lipid changes in ankylosing spondylitis.J. Rheumatol., 42(10): 1842–1845.
  3. Kaneko S., Yamashita H., Sugimori Y. Et al. (2014) Ankylos-ing spondylitis -associated aortitis: a case report. Springerplus, 3: 509.
  4. Roldan CA, Chavez J, Wiest PW, Qualls CR, Craw-ford MH. Aortic root disease and valve disease associ-ated with ankylosing spondylitis. J Am Coll Cardiol. 1998;32(5):1397-1404.
  5. Alves MG, Espirito-Santo J, Queiroz MV, Madeira H, Macieira-Coelho E. Cardiac alterations in ankylosing spondylitis. Angiology. 1988;39(7 Pt 1):567-571.
  6. O'Neill TW, King G, Graham IM, Molony J, Bresnihan B. Echocardiographic abnormalities in ankylosing spondyli-tis. Ann Rheum Dis. 1992;51(5):652-654.
  7. Brewerton DA, Gibson DG, Goddard DH, Jones TJ, Moore RB, Pease CT, Revell PA, et al. The myocardium in ankylosing spondylitis. A clinical, echocardiographic, and histopathological study. Lancet. 1987;1(8540):995-998.
  8. Ribeiro P, Morley KD, Shapiro LM, Garnett RA, Hughes GR, Goodwin JF. Left ventricular function in patients with ankylosing spondylitis and Reiter's disease. Eur Heart J. 1984;5(5):419-422.
  9. Radford EP, Doll R, Smith PG. Mortality among patients with ankylosing spondylitis not given X-ray therapy. N Engl J Med. 1977;297(11):572-576.
  10. Peters MJ, Visman I, Nielen MM, Van Dillen N, Verheij RA, van der Horst-Bruinsma IE, Dijkmans BA, et al. An-kylosing spondylitis: a risk factor for myocardial infarc-tion? Ann Rheum Dis. 2010;69(3):579-581.
  11. Divecha H, Sattar N, Rumley A, Cherry L, Lowe GD, Sturrock R. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflam-matory control subjects: relevance of systemic inflammation. ClinSci (Lond). 2005;109(2):171-176.